Professional Documents
Culture Documents
Chapter 7
©1
Contents
[25 slides]
©1
1. DEOXYRIBONUCLEIC ACID (DNA)
.1 Primary Structure
NH2
5' end 5' end
N N
O O
5' N N Base
O P O CH2
OH
O O P O O
H H 1' NH2
OH
H
3' H H N
O O Base
N O
O P O CH2 O P O O
O
OH H H OH
H H O
H
N NH
O O Base
N N NH2
O P O CH2 O P O O
O
OH H H OH
H H O
H Me
NH O
O Base
N O O P O O
O P O CH2
O OH
OH H H
H H
3' H 3' End
3' End
Sugar phosphate backbone
©1
1. DEOXYRIBONUCLEIC ACID (DNA)
.1 Primary Structure
NH2 O O NH2
N N CH3
N N HN N
N N H2N N N O N O N
HO3PO HO3PO HO3PO HO3PO
O O O O
H H H H H H H H
H H H H H H H
H
HO H HO H HO H HO H
©1
1. DEOXYRIBONUCLEIC ACID (DNA)
.1 Primary Structure
NH2
Base
N
N
Deoxyadenosine N N
phosphate HO3PO
O
Phosphate
H H
H H Sugar
HO H
©1
1. DEOXYRIBONUCLEIC ACID (DNA)
.1 Primary Structure
NH2 O O NH2
N N N CH3
N HN N
N N H2N N
N O N O N
HO HO HO HO
O O O O
H H H H H H H H
H H H H H H H H
HO H HO H HO H HO H
©1
1. DEOXYRIBONUCLEIC ACID (DNA)
.1 Primary Structure
Sugar HOCH2 OH
O
Deoxyribose H H
H H
OH H
Nucleic acid bases
NH2 O NH2 O
N 6 N CH3
N1 6 5 7 HN1 5 7 N3 4 5 HN3 4
5
4 9 8 8
2 2 4 9 2 6 2 1 6
3 3 1
N N H2N N N O N O N
H H H H
Purines Pyrimidines
©1
1. DEOXYRIBONUCLEIC ACID (DNA)
.1 Primary Structure
NH2
N N Adenine (A)
O N N
O P O CH2
O
OH H H NH2
H H
H N
O Cytosine (C)
N O
O P O CH2
O
OH H H
H H O
H
N NH
O
N N NH2
Guanine (G)
O P O CH2
O
OH H H
H H O
H Me
NH
O
N O Thymine (T)
O P O CH2
O
OH H H
H H
H
o
10A • Sugar phosphate backbone
G C
AT
TA
T A
is ionised and faces
Major
groove
G C
G C
TA
outward (favourable
T A
T A
interactions with water)
Minor A T
groove
A T
T A
C G
o
34A • Nucleic acid bases point
G C
TA
T A
inward and pair up A-T or
G C
G C G-C
GC
T A
A T
C G
• Purine pairs with
TA
T A pyrimidine - constant
diameter to helix
DNA DOUBLE HELIX
• Base bairs are stacked (vdw
interactions between pairs)
• Chains are complementary
©1
1. DEOXYRIBONUCLEIC ACID (DNA)
Secondary Structure - Double Helix
Thymine Adenine
o
10A
O P
Me O H2N N O
G C O O
AT
O P 3'
TA NH N N
T A O
Major
G C
G C O N N 5'
groove O O
TA 5' O
T A O
T A
NH2 O O P
Minor A T 3'
N O
groove
A T o O
T A 34A
C G O P N O
G C
O N HN 3'
TA O N N
T A O 5'
G C
5' O H2N O
G C
GC O
T A
A T 3' Cytosine Guanine O P
C G O O
TA O P O
T A O
Trinucleotide
Template Template Template
5' chain X 5' chain 5' chain
A
A A A
X-
C C X C
T T A T A
3'
C G C G C G
3' 3'
G C G C G C
©1
1. DEOXYRIBONUCLEIC ACID (DNA)
3
.3 Tertiary Structure
H H HN
H H
OH OH O N
H
Ribose Uracil
©1
2. RIBONUCLEIC ACID (RNA)
.2 Secondary structure
• Single stranded
©1
2. RIBONUCLEIC ACID (RNA)
3 Tertiary structure
m-
- base pair to the complementary triplet code on
RNA (the codon)
© 1
2. RIBONUCLEIC ACID (RNA)
.4 Transcription
G
U
A
U
C
U
G
mRNA U
C
C
G G C
T C T G C U
A A A U A U
T T T A T A
C A C U A
T G T C G
G A G U A
T
C
C
C
A
G
T
C
G
U
C
C
A
G
mRNA
C
C G C C G
T G T C G
T A T U A
A A A U A
T A T
Growing
protein chain
His
Ribosome
60S
P-site
A-site
GCU GCA
CGA CAU GUC
mRNA
40S
©1
2. RIBONUCLEIC ACID (RNA)
Translation - protein synthesis
Protein chain
transferred
OH His
Ribosome
60S
P-site
A-site
GCU GCA
CGA CAU GUC
mRNA
40S
©1
2. RIBONUCLEIC ACID (RNA)
Translation - protein synthesis
OH Protein chain
transferred
His
GCU
Ribosome
60S
P-site
A-site
GCA
CGA CAU GUC
mRNA
40S
©1
2. RIBONUCLEIC ACID (RNA)
Translation - protein synthesis
Protein chain
transferred
His
Ribosome
60S
P-site
A-site
GCA
CGA CAU GUC
mRNA
40S
©1
2. RIBONUCLEIC ACID (RNA)
Translation - protein synthesis
Protein chain
transferred
His Val
tRNA
Ribosome
60S
P-site
A-site
GCA CAG
CGA CAU GUC
mRNA
40S
Translocation
©1
2. RIBONUCLEIC ACID (RNA)
Translation - protein synthesis
PEPTIDE
NH NH2
R C H R' C H
O C O C
HO O HO O
H
H
H H H OH H H H OH
O O P O PEPTIDE
Adenine O O P O Adenine
O O NH
t RNA t RNA R C H
O C
Transfer of NH
growing peptide
chain to next R' C H
amino acid HO OH O C
H H
H H HO O
OH H H
O O P O H H
Adenine OH
O O O P O
Adenine
t RNA O
©1 t RNA
2. RIBONUCLEIC ACID (RNA)
Translation - protein synthesis
mRNA
view Ribosome
Amino acid
DNA
tRNA
mRNA
Translation
Transcription
Nucleus
Protein
©1
Patrick
An Introduction to Medicinal Chemistry 3/e
Chapter 7
NUCLEIC ACIDS AS
DRUG TARGETS
©1
Contents
[21 slides]
©1
3. DRUGS ACTING ON DNA
1 Intercalating agents
Mechanism of action
• Contain planar aromatic or heteroaromatic
ring systems
• Planar systems slip between the layers of
nucleic acid pairs and disrupt the shape of
the helix
• Preference is often shown for the minor or
major groove
• Intercalation prevents replication and
transcription
• Intercalation inhibits topoisomerase II
©1
3. DRUGS ACTING ON DNA
Topoisomerase II
• Relieves the strain in the DNA helix by
temporarily cleaving the DNA chain and crossing an
intact strand through the broken strand
Topo II
Tyr
5' 3'
3' 5'
DNA
©1
3. DRUGS ACTING ON DNA
Topoisomerase II
• Relieves the strain in the DNA helix by
temporarily cleaving the DNA chain and crossing
an intact strand through the broken strand
Topo II
Tyr
5' 3'
3' 5'
DNA
Tyr
Topo II
©1
3. DRUGS ACTING ON DNA
Topoisomerase II
• Relieves the strain in the DNA helix by
temporarily cleaving the DNA chain and crossing an
intact strand through the broken strand
Topo II
Tyr
DNA
Tyr
Topo II
Topo II
Tyr
5' 3'
3' 5'
Tyr
Topo II
Topo II
Tyr
5' 3'
3' 5'
5' Base
O
H H
5' Base
O H H
H H TopoII HO H
H H TopoII
HO Tyr
O Tyr
O H
O P O P
O O Base O O Base
O O
H H H H
H H H H
O H O H
3' 3'
©1
3. DRUGS ACTING ON DNA
1 Intercalating agents
xample - Proflavine
H2N N NH2
Proflavine
ar tricyclic system
amino substituents are protonated and charged
as a topical antibacterial agent in the second wor
ets bacterial DNA
toxic for systemic use
©1
3. DRUGS ACTING ON DNA
1 Intercalating agents
xample - Proflavine
Proflavine
G C
AT
TA
T A
G C
H 3N N NH3
G C
sugar phosphate
TA
T A backbone
T A
A T T A
A T
T A
C G
G C
proflavine
TA H 3N NH3
T A
G C
G C O O
GC
T A G C
A T
C G
TA
T A
H
CH3 CH2CH 3
H NH CH (CH2)3 N
HO N CH2CH3
MeO
Cl N
N
Quinine Chloroquine
©1
3. DRUGS ACTING ON DNA
.2 Alkylating agents
• Contain highly electrophilic groups
• Form covalent bonds to nucleophilic groups
in DNA (e.g. 7-N of guanine)
• Prevent replication and transcription
• Useful anti-tumour agents
• Toxic side effects (e.g. alkylation of
proteins)
xample
echlorethamine (nitrogen mustard)
Cl
CH3 N
Cl ©1
3. DRUGS ACTING ON DNA
.2 Alkylating agents
Cross linking
X X
X X
Nu Nu
Nu
Nu Nu Nu
Nu
Nu
©1
3. DRUGS ACTING ON DNA
.2 Alkylating agents
Mechanism of action
DNA DNA
H G = Guanine
O N NH2
H
Cl O N NH2
N
N
+ N
CH3 N CH3 N N N
CH3 N N
G
Cl Cl
Cl
Mechlorethamine Aziridine ion
N N NH2
N N NH2
N NH
NH
N G
O O
DNA DNA
H
O N NH2
H
O N NH2
N
N
N N
N
Crosslinked DNA
CH3 N N
+
N N N NH2
N N NH2
NH
NH CH3 N
©1
N
O
O
3. DRUGS ACTING ON DNA
.2 Alkylating agents
echlorethamine analogues
Cl
Cl O
N
N HN
Cl
Cl O N
H
Cisplatin Mitomycin C
O CH2OCONH2
Cl NH3
H 2N OMe
Pt
Cl NH3 N NH
Me
O
Reduction -MeOH
N NH N NH Me N NH
Me Me H
O OH OH
O H
C NH2
H O
O CH2OCONH 2 OH CH2
H2N H2N H2 N-DNA
-H +
Ring H2 N-DNA NH-DNA
opening N
Me Me N
NH2 NH2
OH OH
Alkylating agent
O Guanine
HN N
N N
NH
NH-DNA OH
OH CH2 O Guanine
CH2
H2N N
H2N HN
NH
NH-DNA N
-CO2 N
Me N
-NH3 Me N
NH2
NH2 OH
OH
Crosslinked DNA ©1
3. DRUGS ACTING ON DNA
.3 Chain cutters
CONH2 NH2
N
NH2 O Bleomycin
H
O
N R
Used vs skin cancer
N N CH3 O
H
O HO N
H2N O NH N S
CH3 HN O
N CH3 HO CH3 S
H
HO O N
OH
O N
O H BLEOMYCIN A2 R = NHCH2CH2CH2SMe2
OH OH
BLEOMYCIN B2 R = NHCH2CH2CH2CH2NHC(NH2)=NH
OH
O
OH
O NH2
O
HO
CH3 O NHCO2Me
S S
I H3C H3C S
S O H
H3C
O N O Calicheamicin 1I
O OMe HHO
OH O Antitumour agent
OMe
H3C O
HO H O
MeO N enediyne
OH H3C MeO system
H
O
HO O O
HO HO
Michael
NHCO2Me NHCO2Me addition NHCO2Me
S S S
S R R R
MeS
Nu
O O
Cycloaromatisation HO HO
NHCO2Me
NHCO2Me H
DNA DNA
(Diradical) S
S
O2 R
R H
Oxidative
cleavage
©1
Patrick
An Introduction to Medicinal Chemistry 3/e
Chapter 7
NUCLEIC ACIDS AS
DRUG TARGETS
©1
Contents
[7 slides]
©1
4. DRUGS ACTING ON rRNA
NH
Antibiotics NH
H HN C NH2
H2N C NH
H
OH H
H HO
OH OH Me
H H OH
HO H Me N
H
O
O2N H O
CH2OH O CHO
O R H
HN H Me H
Me OH Me OH Streptomycin
C O H
O CHCl2 OH O
HO O
O Me Me H
H H CH2OH
Chloramphenicol H MeHN
H
(vs typhoid) H H
H H Me
OMe O Me H OH OH H
C
CH3 NMe2
O
O HO
Rifamycins H3C CH3
HO O
OH O OH O O HO O CH3
OH
Protein synthesis
m-RNA
antisense
molecule
A G U C U A C G U U
G U A A U C A G A U G C A A A A G U
m-RNA
©1
5. DRUGS ACTING ON mRNA
Antisense Therapy
Advantages
• Same effect as an enzyme inhibitor or
receptor antagonist
• Highly specific where the oligonucleotide is
17 nucleotides or more
• Smaller dose levels required compared to
inhibitors or antagonists
• Potentially less side effects
Disadvantages
• ‘Exposed’ sections of mRNA must be targeted
• Instability and polarity of oligonucleotides
(pharmacokinetics)
• Short lifetime of oligonucleotides and© poor
1
6. Drugs related to nucleic acid building blocks
amples: Antiviral agents
O
O CH3
zidothymidine (AZT) CH3
HN
HN
Zidovudine;Retrovir)
O N
O N O O O
HO P O P O P O O
HO O OH OH OH
N3
N3
Chain terminating
group
me inhibitor
is phosphorylated to a triphosphate in the body
hosphate has two mechanisms of action
- inhibits a viral enzyme (reverse transcriptase)
- added to growing DNA chain and acts as chain term
©1
gs related to nucleic acid building blocks
amples: Antiviral agents
O
N N
HN N
AcO
N N N NH2
H2 N N
O Chain OAc
Chain
HO terminating terminating
group group
Acyclovir Famciclovir
(Zovirax) (Famvir)
otes:
ame mechanisms of action as AZT
sed vs herpes simplex and shingles
©1
gs related to nucleic acid building blocks
es: Antisense nucleotides - see earlier
Uracil mustard - see earlier
©1